Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 15, 2023

BUY
$1.11 - $2.05 $15,207 - $28,084
13,700 New
13,700 $16,000
Q2 2021

Jul 30, 2021

SELL
$2.91 - $3.83 $142,008 - $186,904
-48,800 Closed
0 $0
Q1 2021

May 06, 2021

SELL
$3.47 - $4.75 $6,940 - $9,500
-2,000 Reduced 3.94%
48,800 $180,000
Q4 2020

Feb 08, 2021

SELL
$3.2 - $4.98 $9,600 - $14,940
-3,000 Reduced 5.58%
50,800 $210,000
Q3 2020

Nov 12, 2020

SELL
$3.69 - $7.09 $5,535 - $10,635
-1,500 Reduced 2.71%
53,800 $210,000
Q2 2020

Aug 13, 2020

BUY
$3.58 - $7.44 $53,342 - $110,856
14,900 Added 36.88%
55,300 $411,000
Q1 2020

May 14, 2020

BUY
$3.49 - $9.2 $30,014 - $79,120
8,600 Added 27.04%
40,400 $181,000
Q3 2019

Nov 14, 2019

SELL
$4.75 - $8.38 $15,200 - $26,816
-3,200 Reduced 9.14%
31,800 $223,000
Q2 2019

Aug 14, 2019

BUY
$6.4 - $10.94 $14,720 - $25,162
2,300 Added 7.03%
35,000 $248,000
Q1 2019

May 14, 2019

BUY
$6.1 - $10.3 $46,970 - $79,310
7,700 Added 30.8%
32,700 $337,000
Q4 2018

Feb 13, 2019

BUY
$5.84 - $11.92 $43,216 - $88,208
7,400 Added 42.05%
25,000 $155,000
Q3 2018

Nov 08, 2018

BUY
$12.43 - $29.76 $49,720 - $119,040
4,000 Added 29.41%
17,600 $219,000
Q2 2018

Aug 13, 2018

BUY
$18.75 - $28.46 $255,000 - $387,056
13,600 New
13,600 $381,000

Others Institutions Holding OPTN

About OptiNose, Inc.


  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $40M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.